[1]
“Use of weight loss agents in the treatment of obesity: comparison of adverse effects in the use of orlistat versus sibutramine”, RSD, vol. 11, no. 13, p. e415111335776, Oct. 2022, doi: 10.33448/rsd-v11i13.35776.